Regent Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,899
| Closed | -$406K | – | 216 |
|
|
2021
Q2 | $406K | Sell |
5,899
-71
| -1% | -$4.74K | 0.1% | 158 |
|
|
2021
Q1 | $386K | Sell |
5,970
-100
| -2% | -$6.45K | 0.1% | 150 |
|
|
2020
Q4 | $354K | Hold |
6,070
| – | – | 0.1% | 151 |
|
|
2020
Q3 | $384K | Sell |
6,070
-50
| -0.8% | -$3.47K | 0.12% | 134 |
|
|
2020
Q2 | $471K | Sell |
6,120
-975
| -14% | -$74.7K | 0.16% | 119 |
|
|
2020
Q1 | $530K | Sell |
7,095
-450
| -6% | -$31.1K | 0.22% | 98 |
|
|
2019
Q4 | $490K | Hold |
7,545
| – | – | 0.15% | 131 |
|
|
2019
Q3 | $478K | Sell |
7,545
-250
| -3% | -$16.3K | 0.16% | 136 |
|
|
2019
Q2 | $527K | Sell |
7,795
-185
| -2% | -$12.2K | 0.17% | 129 |
|
|
2019
Q1 | $519K | Sell |
7,980
-3,920
| -33% | -$261K | 0.17% | 130 |
|
|
2018
Q4 | $744K | Sell |
11,900
-320
| -3% | -$22.4K | 0.28% | 96 |
|
|
2018
Q3 | $944K | Hold |
12,220
| – | – | 0.3% | 90 |
|
|
2018
Q2 | $866K | Sell |
12,220
-655
| -5% | -$46.3K | 0.29% | 94 |
|
|
2018
Q1 | $971K | Sell |
12,875
-5,815
| -31% | -$462K | 0.33% | 83 |
|
|
2017
Q4 | $1.34M | Sell |
18,690
-1,087
| -5% | -$82.5K | 0.44% | 70 |
|
|
2017
Q3 | $1.6M | Sell |
19,777
-840
| -4% | -$64.2K | 0.54% | 58 |
|
|
2017
Q2 | $1.46M | Sell |
20,617
-12,900
| -38% | -$858K | 0.51% | 58 |
|
|
2017
Q1 | $2.28M | Sell |
33,517
-4,350
| -11% | -$306K | 0.86% | 33 |
|
|
2016
Q4 | $2.71M | Sell |
37,867
-705
| -2% | -$52.4K | 1.39% | 17 |
|
|
2016
Q3 | $3.05M | Sell |
38,572
-685
| -2% | -$55.6K | 1.59% | 14 |
|
|
2016
Q2 | $3.27M | Sell |
39,257
-888
| -2% | -$78.8K | 1.78% | 11 |
|
|
2016
Q1 | $3.69M | Hold |
40,145
| – | – | 2.05% | 9 |
|
|
2015
Q4 | $4.06M | Sell |
40,145
-300
| -0.7% | -$31.2K | 2.17% | 9 |
|
|
2015
Q3 | $3.97M | Sell |
40,445
-35
| -0.1% | -$3.89K | 2.19% | 8 |
|
|
2015
Q2 | $4.74M | Sell |
40,480
-2,245
| -5% | -$245K | 2.39% | 7 |
|
|
2015
Q1 | $4.19M | Buy |
42,725
+465
| +1% | +$47.2K | 2.13% | 8 |
|
|
2014
Q4 | $3.98M | Sell |
42,260
-3,375
| -7% | -$349K | 2.04% | 9 |
|
|
2014
Q3 | $4.86M | Sell |
45,635
-4,412
| -9% | -$432K | 2.49% | 5 |
|
|
2014
Q2 | $4.15M | Buy |
50,047
+330
| +0.7% | +$25.7K | 2.05% | 7 |
|
|
2014
Q1 | $3.52M | Buy |
49,717
+3,625
| +8% | +$284K | 1.86% | 12 |
|
|
2013
Q4 | $3.46M | Buy |
46,092
+10,485
| +29% | +$730K | 1.94% | 8 |
|
|
2013
Q3 | $2.24M | Buy |
35,607
+4,167
| +13% | +$249K | 1.48% | 14 |
|
|
2013
Q2 | $1.61M | Buy |
+31,440
| New | +$1.64M | 1.24% | 24 |
|
Other funds holding GILD
Regent Investment Management's GILD Position: Q3 2021 in Review
Regent Investment Management sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 5,899 shares — an estimated $406K sold.
Regent Investment Management first reported a position in GILD in Q2 2013 and held it in 33 quarters. The position peaked at $4.86M in Q3 2014. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.
- Regent Investment Management reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
- Regent Investment Management sold 5,899 Gilead Sciences shares in Q3 2021, an estimated $406K.
- Regent Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 33 quarters.
- Regent Investment Management's Gilead Sciences position peaked at $4.86M in Q3 2014.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.
Based on Regent Investment Management's 13F filing for Q3 2021, filed 21 Oct 2021.